FDAnews Drug Daily Bulletin

ACCENTIA BIOPHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

Nov. 2, 2005
A A

Accentia Biopharmaceuticals, Inc. announced today the pricing of its initial public offering of 2,400,000 shares of its common stock at a price to the public of $8.00 per share. All of the shares are being offered by Accentia. In addition, Accentia has granted to the underwriters a 30-day option to purchase up to an additional 360,000 shares to cover over-allotments, if any. Accentia's common stock will be listed on the Nasdaq National Market under the symbol "ABPI." The offering is expected to close on November 2, 2005.
Business Wire